FDA is encouraging testosterone sponsors to work together on a single clinical trial to address whether the drugs cause an increased risk of heart attack or stroke; however, sponsors may elect to work on the new post-marketing requirement alone.
Information about a possible increased risk of heart attacks and stroke in patient taking testosterone also needs to be added...